Among genes deregulated in ERG-rearranged prostate cancer, at least two independent studies identified Tudor domain-containing protein 1 (TDRD1) as the most differentially expressed gene between ERG rearrangement-positive and -negative prostate cancer, apart from ERG itself [16], [23]. This evidence concerns the gene ERG and prostate carcinoma.